Related Experiment Video

Updated: Aug 12, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 11, 2013

A comprehensive look at Respiratory Syncytial Virus (RSV): from pathogenesis to prevention

Omid Salahi Ardekani1, Parisa Hasannezhad2,3, Yasaman Goudarzi1

  • 1Department of Virology, Faculty of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Tropical Diseases, Travel Medicine and Vaccines
|August 11, 2026
PubMed

Insights

Respiratory Syncytial Virus (RSV) significantly impacts global health, especially in infants. New vaccines and monoclonal antibodies offer promising prevention strategies against this severe respiratory pathogen.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • Respiratory Syncytial Virus (RSV) is a major cause of severe respiratory illness in infants and children globally.
  • RSV infection presents with variable severity, ranging from mild upper respiratory symptoms to life-threatening lower respiratory tract disease.
  • The virus has a substantial impact on healthcare systems and public health resources.

Purpose of the Study:

  • To provide a comprehensive overview of Respiratory Syncytial Virus (RSV).
  • To discuss the epidemiology, clinical manifestations, and therapeutic strategies for RSV.
  • To review the latest advancements in RSV vaccine development and its potential as an oncolytic agent.

Main Methods:

  • This narrative review synthesizes existing literature on RSV.
  • Key aspects covered include epidemiology, clinical presentation, treatment options, and vaccine research.
  • The review also explores the emerging role of RSV in oncolytic virotherapy.

Main Results:

  • Three RSV vaccines (Arexvy, Abrysvo, mRESVIA) are now FDA-approved.
  • Monoclonal antibodies like Nirsevimab and Clesrovimab are recommended for infant protection.
  • Understanding RSV seasonality is crucial for effective immunization program planning.

Conclusions:

  • RSV poses a significant global health challenge, necessitating effective prevention and treatment strategies.
  • The development of vaccines and monoclonal antibodies marks a significant advancement in combating RSV.
  • Further research into RSV, including its oncolytic potential, is warranted.

Keywords:
Antiviral treatmentsClinical manifestationsEpidemiologyOncolytic virusRespiratory syncytial virusVaccines

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Overview of Respiratory System01:23

Overview of Respiratory System

The respiratory system is a complex biological apparatus that facilitates the exchange of gases, specifically oxygen and carbon dioxide, between our bodies and the environment. This system plays a vital role in the physiological process of respiration, an essential function for sustaining life.
What is the Respiratory System?
The respiratory system consists of a series of organs responsible for taking in oxygen and expelling carbon dioxide. The primary function of the respiratory system is to...
Coronavirus01:29

Coronavirus

Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...